FDA Grants Breakthrough Device Designation to MeMed Severity Test for Patients with Suspected Sepsis

[#item_full_content]ANDOVER, Mass. & HAIFA, Israel–(BUSINESS WIRE)– #BDD–This designation advances the management of acute infections and sepsis by empowering clinicians with timely insights for better patient outcomes.